<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Silo Wellness Inc — News on 6ix</title>
    <link>https://6ix.com/company/silo-wellness-inc</link>
    <description>Latest news and press releases for Silo Wellness Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 20:15:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/silo-wellness-inc" rel="self" type="application/rss+xml" />
    <item>
      <title>Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-strategic-business-expansion-into-multi-billion-dollar-ai-agent-market-with-acquisition-of-managed-ai-agent-platform-qwikagents-1</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-strategic-business-expansion-into-multi-billion-dollar-ai-agent-market-with-acquisition-of-managed-ai-agent-platform-qwikagents-1</guid>
      <pubDate>Wed, 22 Apr 2026 20:15:00 GMT</pubDate>
      <description>Launch of Dedicated AI Subsidiary Positions Company for New Revenue Streams While Advancing PTSD ...</description>
    </item>
    <item>
      <title>Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-positioned-to-advance-treatment-targeting-ptsd-as-president-trump-signs-executive-order-aimed-at-accelerating-research-and-treatment-based-upon-psychedelics</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-positioned-to-advance-treatment-targeting-ptsd-as-president-trump-signs-executive-order-aimed-at-accelerating-research-and-treatment-based-upon-psychedelics</guid>
      <pubDate>Mon, 20 Apr 2026 10:34:00 GMT</pubDate>
      <description>SPC-15 Intranasal PTSD Program Aligns with Federal Push to Fast-Track Novel Mental Health Therapi...</description>
    </item>
    <item>
      <title>Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-receives-european-patent-allowance-for-licensed-novel-ptsd-prevention-therapy</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-receives-european-patent-allowance-for-licensed-novel-ptsd-prevention-therapy</guid>
      <pubDate>Mon, 06 Apr 2026 20:15:00 GMT</pubDate>
      <description>EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands S...</description>
    </item>
    <item>
      <title>Silo Pharma Announces Share Buyback Program</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-share-buyback-program</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-share-buyback-program</guid>
      <pubDate>Mon, 23 Feb 2026 21:15:00 GMT</pubDate>
      <description>Sarasota, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) --     Silo Pharma, Inc.    (Nasdaq: SILO) (&amp;#x201C;...</description>
    </item>
    <item>
      <title>Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-receives-notice-of-allowance-in-japan-for-spc-15-expanding-global-intellectual-property-portfolio</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-receives-notice-of-allowance-in-japan-for-spc-15-expanding-global-intellectual-property-portfolio</guid>
      <pubDate>Wed, 18 Feb 2026 13:28:00 GMT</pubDate>
      <description>SARASOTA, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (&amp;#x201C;Silo&amp;#x...</description>
    </item>
    <item>
      <title>Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-executes-letter-of-intent-with-allucent-to-support-phase-1-clinical-development-of-spc-15</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-executes-letter-of-intent-with-allucent-to-support-phase-1-clinical-development-of-spc-15</guid>
      <pubDate>Tue, 30 Dec 2025 13:05:00 GMT</pubDate>
      <description>Planned SAD and MAD Studies Mark Key Clinical Inflection Point for Intranasal PTSD and Anxiety   ...</description>
    </item>
    <item>
      <title>Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-partners-with-allucent-to-support-planned-fda-investigational-new-drug-application-for-spc-15-as-a-therapeutic-for-ptsd</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-partners-with-allucent-to-support-planned-fda-investigational-new-drug-application-for-spc-15-as-a-therapeutic-for-ptsd</guid>
      <pubDate>Mon, 17 Nov 2025 13:05:00 GMT</pubDate>
      <description>SARASOTA, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (&amp;#x201C;Silo&amp;#x...</description>
    </item>
    <item>
      <title>Silo Pharma Selects Alphaledger&apos;s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-selects-alphaledgers-t12-fund-for-tokenized-real-world-asset-investments-on-solana-blockchain</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-selects-alphaledgers-t12-fund-for-tokenized-real-world-asset-investments-on-solana-blockchain</guid>
      <pubDate>Wed, 29 Oct 2025 12:25:00 GMT</pubDate>
      <description>Investment vehicle provides diversified exposure to real-world assets and expected to reduce port...</description>
    </item>
    <item>
      <title>Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-issues-update-on-milestone-achievements-in-ptsd-drug-development-and-new-digital-assets-treasury-program</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-issues-update-on-milestone-achievements-in-ptsd-drug-development-and-new-digital-assets-treasury-program</guid>
      <pubDate>Thu, 23 Oct 2025 12:45:00 GMT</pubDate>
      <description>Significant milestones are approaching in drug development; additional digital asset purchases ex...</description>
    </item>
    <item>
      <title>Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company&apos;s Commitment to Multi-Chain Growth</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-expands-crypto-treasury-with-first-strategic-bitcoin-purchase-reinforcing-companys-commitment-to-multi-chain-growth</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-expands-crypto-treasury-with-first-strategic-bitcoin-purchase-reinforcing-companys-commitment-to-multi-chain-growth</guid>
      <pubDate>Wed, 08 Oct 2025 12:45:00 GMT</pubDate>
      <description>SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) -- &amp;#xA0; Silo Pharma, Inc. (Nasdaq: SILO) (&amp;#x201C;...</description>
    </item>
    <item>
      <title>Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-acquires-researchcoin-rsc-crypto-tokens-in-support-of-decentralized-science-desci</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-acquires-researchcoin-rsc-crypto-tokens-in-support-of-decentralized-science-desci</guid>
      <pubDate>Mon, 06 Oct 2025 12:10:00 GMT</pubDate>
      <description>Company invests in DeSci blockchain innovation and         purchases native coin of ResearchHub, ...</description>
    </item>
    <item>
      <title>Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-closing-of-dollar25-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-closing-of-dollar25-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules</guid>
      <pubDate>Wed, 01 Oct 2025 20:20:00 GMT</pubDate>
      <description>SARASOTA, FL, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (&amp;#x201C;Silo&amp;#x...</description>
    </item>
    <item>
      <title>Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-dollar25-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-dollar25-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules</guid>
      <pubDate>Tue, 30 Sep 2025 12:02:00 GMT</pubDate>
      <description>SARASOTA, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (&amp;#x201C;Silo&amp;#...</description>
    </item>
    <item>
      <title>Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-updates-strategic-agreement-with-fireblocks-to-secure-crypto-treasury-management</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-updates-strategic-agreement-with-fireblocks-to-secure-crypto-treasury-management</guid>
      <pubDate>Mon, 29 Sep 2025 18:30:00 GMT</pubDate>
      <description>Fireblocks is a globally recognized leader in the digital assets space, facilitating the secure t...</description>
    </item>
    <item>
      <title>Silo Wellness Submits CSE Listing Statement for Review of Born Defense Proposed Change of Business</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-wellness-submits-cse-listing-214700745</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-wellness-submits-cse-listing-214700745</guid>
      <pubDate>Sun, 28 Sep 2025 21:47:00 GMT</pubDate>
      <description>Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - September 28, 2025) - Silo Wellness Inc. (CSE: SILO) (&quot;Silo&quot; or the &quot;Company&quot;), to be renamed Born Defense Inc., is pleased to announce that it has submitted its listing statement (the &quot;Listing Statement&quot;) with the Canadian Securities Exchange (the &quot;CSE&quot;) on September 26, 2025, for review in connection with its previously announced proposed change of business to an investment issuer focused on the defense and national security sectors.The...</description>
    </item>
    <item>
      <title>Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-signs-strategic-agreement-with-fireblocks-to-advance-crypto-treasury-strategy-acquisition-and-security</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-signs-strategic-agreement-with-fireblocks-to-advance-crypto-treasury-strategy-acquisition-and-security</guid>
      <pubDate>Tue, 23 Sep 2025 12:38:00 GMT</pubDate>
      <description>SARASOTA, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) --   Silo Pharma, Inc. (Nasdaq: SILO) (&amp;#x201C;Silo...</description>
    </item>
    <item>
      <title>Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-initial-investment-in-ethereum-and-solana-under-cryptocurrency-treasury-strategy</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-announces-initial-investment-in-ethereum-and-solana-under-cryptocurrency-treasury-strategy</guid>
      <pubDate>Tue, 16 Sep 2025 12:11:00 GMT</pubDate>
      <description>Strategic capital deployment advances Company&amp;#x2019;s blockchain treasury&amp;#xA0;model and biophar...</description>
    </item>
    <item>
      <title>Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-adds-japanese-patent-to-expanding-global-ip-portfolio-for-licensed-ptsd-drug</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-adds-japanese-patent-to-expanding-global-ip-portfolio-for-licensed-ptsd-drug</guid>
      <pubDate>Tue, 09 Sep 2025 13:10:00 GMT</pubDate>
      <description>SARASOTA, FL, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (&amp;#x201C;Silo&amp;#...</description>
    </item>
    <item>
      <title>Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharma-secures-australian-patent-covering-licensed-ptsd-drug-candidate-expanding-global-ip-portfolio</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharma-secures-australian-patent-covering-licensed-ptsd-drug-candidate-expanding-global-ip-portfolio</guid>
      <pubDate>Wed, 03 Sep 2025 12:25:00 GMT</pubDate>
      <description>SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (&amp;#x201C;Silo&amp;#...</description>
    </item>
    <item>
      <title>Silo Pharma&apos;s Alzheimer&apos;s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal</title>
      <link>https://6ix.com/company/silo-wellness-inc/news/silo-pharmas-alzheimers-candidate-spc-14-featured-in-leading-scientific-peer-reviewed-journal</link>
      <guid isPermaLink="true">https://6ix.com/company/silo-wellness-inc/news/silo-pharmas-alzheimers-candidate-spc-14-featured-in-leading-scientific-peer-reviewed-journal</guid>
      <pubDate>Thu, 21 Aug 2025 18:00:00 GMT</pubDate>
      <description>Manuscript featured in leading open-access scientific journal Alzheimer&amp;#x2019;s Research &amp;amp; T...</description>
    </item>
  </channel>
</rss>